Washington, D.C. partner recognized as lawyer advancing gender diversity in STEM fields.
Dr. Reba Rabenstein advises clients regarding complex intellectual property and trade secret litigation, arbitration, and strategy across industries, with a particular focus on leading branded pharmaceutical and biotechnology companies.
Dr. Rabenstein is a seasoned trial attorney representing clients at all stages of litigation, including pre-suit investigation, litigation, trial, and appeal. She has gone to trial in multiple district courts, including the District of Delaware, the Southern District of New York, and in the District of Massachusetts, where she participated in the first virtual patent trial in that district.
Having worked both for patentees and patent defendants, Dr. Rabenstein helps her clients strategically navigate cutting-edge legal issues to achieve successful outcomes.
For pharmaceutical and biotechnology companies, she regularly handles cases involving:
- Regenerative medicine
- Gene therapy
- Molecular biological techniques
- Small molecule pharmaceuticals
Drawing on her academic experience in cellular and molecular biology, physiology, and pharmacology, she is well-positioned to understand the science and translate it to judges and juries. In addition, Dr. Rabenstein leverages her litigation experience to advise clients on due diligence matters and business strategies regarding intellectual property.
Prior to joining Latham, Dr. Rabenstein served as a law clerk to Chief Judge Kimberly A. Moore of the United States Court of Appeals for the Federal Circuit. She earned her JD from the University of Michigan Law School, where she served as executive note editor of the Michigan Telecommunications and Technology Law Review.
As a result of her graduate and undergraduate research and various collaborative efforts, Dr. Rabenstein has co-authored several scientific articles.